CCME Global Limited (formerly known as genesis ibrc India Limited) has successfully completed a significant preferential allotment of equity shares, with promoter Padmanaban Krishnamoorthy filing mandatory regulatory disclosures for his substantial acquisition. The company's Preferential Issue Committee approved the allotment during a meeting held on March 26, 2026.

Allotment Details

The company allotted 3,22,50,000 fully paid-up equity shares with a face value of INR 10 each at par, generating total proceeds of INR 32,25,00,000. The allotment was made through a preferential issue on a private placement basis to 11 investors, comprising both promoters and non-promoters.

SEBI Regulatory Disclosure

Promoter Padmanaban Krishnamoorthy filed a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, on March 27, 2026. The disclosure details his acquisition of 2,00,00,000 equity shares through the preferential allotment dated March 26, 2026.

Investor Composition

The allotment was distributed among promoters and non-promoters, with the largest allocation going to promoter Mr. Padmanaban Krishnamoorthy.

Impact on Share Capital

The preferential allotment has significantly enhanced the company's capital structure. The issued, subscribed and paid-up capital has increased substantially following this allotment.

Regulatory Compliance

The allotment was conducted in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, the Companies Act, 2013, and related rules. The issue price of INR 10 was determined based on a valuation report issued by an Independent Registered Valuer dated January 28, 2026.

The newly allotted equity shares rank pari passu with existing equity shares in all respects, including dividend payment and voting rights. This allotment represents a partial subscription of the originally proposed 4,02,50,000 equity shares that were approved by shareholders through postal ballot on March 5, 2026. The company is listed on BSE Limited.

Genesis IBRC India Limited has received in-principle approval from BSE Limited for a preferential issue of equity shares worth ₹40.25 crore. The company announced this significant corporate development on March 13, 2026, marking a key milestone in its capital raising initiative.

BSE Approval Details

The approval was granted through BSE's letter reference number LOD/PREF/GB/FIP/1863/2025-26 dated March 12, 2026. The exchange has provided its consent for the company to proceed with the preferential issue under Regulation 28 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Regulatory Compliance Requirements

BSE has outlined comprehensive compliance requirements that Genesis IBRC must fulfill for the successful completion of this preferential issue. The company must ensure strict adherence to multiple regulatory frameworks including the Companies Act 2013, Securities Contracts (Regulation) Act 1956, SEBI Act 1992, and the Depositories Act 1996.

The exchange has specifically emphasized compliance with:

• Chapter V of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018
• SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
• Listing Agreement provisions signed with BSE

Internal Controls and Monitoring

BSE has advised Genesis IBRC to strengthen internal controls to monitor trades executed by proposed allottees in the company's scrip before allotment. The company must obtain undertakings from allottees confirming they will not engage in intra-day trading or sell company shares until the allotment date, as required under SEBI ICDR Regulations.

Key monitoring requirements include:

• Verification of allottee compliance with trading restrictions
• Ensuring adherence to Regulation 167(6) of SEBI ICDR Regulations 2018
• Understanding that non-compliance may impact share listing

Post-Issue Formalities and Timeline

Following the allotment of securities, Genesis IBRC must submit a listing application without delay, along with applicable fees, in accordance with Regulation 14 of the LODR Regulations. The company has been specifically notified that it must apply for listing within twenty days from the date of allotment, as per Schedule XIX – Para (2) of ICDR Regulations and SEBI circular dated June 21, 2023.

Non-compliance with the twenty-day timeline will attract penalties as specified in the relevant SEBI circular. BSE reserves the right to withdraw this in-principle approval if any submitted information is found to be incomplete, incorrect, misleading, or in contravention of applicable regulations.